SCHEMBL8094954

SCHEMBL8094954

CS(=O)(=O)Nc1ccccc1C(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.78
MEN1 O00255 7/20 0.78
ALDH1A1 P00352 7/20 0.78
KDM4E B2RXH2 7/20 0.78
SMN1; SMN2 Q16637 5/20 0.78
HTT P42858 4/20 0.78
HPGD P15428 4/20 0.78
MAPK1 P28482 1/20 0.63
TSHR P16473 2/20 0.60
ATM Q13315 1/20 0.59
HSD17B10 Q99714 4/20 0.55
RCE1 Q9Y256 1/20 0.55
LMNA P02545 3/20 0.55
RECQL P46063 1/20 0.55
MAPT P10636 2/20 0.53
BDKRB1 P46663 1/20 0.53
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
CRHBP P24387 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19221685 0.88 HTT (0.72) KMT2AMEN1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL6814541 0.86 HTT (0.70) KMT2AMEN1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL16088703 0.86 HTT (0.70) KMT2AMEN1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL16127827 0.82 HTT (0.65) KMT2AMEN1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL14267570 0.82 MEN1 (0.73) KMT2AMEN1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL24073684 0.81 SMN1; SMN2 (0.74) KMT2AMEN1ALDH1A1SMN1; SMN2HTT
SCHEMBL30142707 0.81 SMN1; SMN2 (0.74) KMT2AMEN1ALDH1A1SMN1; SMN2HTT
SCHEMBL7078122 0.80 HTT (0.66) KMT2AMEN1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL7128109 0.79 MEN1 (0.64) KMT2AMEN1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL16127954 0.79 HTT (0.61) KMT2AMEN1ALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP claimed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP claimed
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed